Phase 2 Trials

The latest news about Phase 2 Trials: headlines, AI summaries and the full story from every source.

• Cue Biopharma Shares Drop Over 30% Following Disappointing Phase 2 Trial Results for Chronic Spontaneous Urticaria Treatment Seeking Alpha · September 21, 2026, 15:20 UTC